News Releases

July 9, 2010

Emory Eye Center Researcher Elected President of National Research Organization

Media contact:
Joy Bell, 404-778-3711

Jeffrey Boatright, PhD(ATLANTA) Emory Eye Center Associate Professor Jeffrey Boatright, PhD, has been voted president of the Association for Research in Vision and Ophthalmology (ARVO). ARVO is the premier vision research organization in the United States. He will assume the presidency in May 2011.

Founded in 1928 in Washington, D.C. by 73 ophthalmologists, the Association's membership now numbers more than 12,500 individuals and continues to grow. Some 42% of members reside in over 80 countries outside the United States. The membership is multidisciplinary and consists of both clinical and basic researchers. ARVO encourages and assists research, training, publication and knowledge-sharing in vision and ophthalmology.

“Jeff Boatright is a terrific choice for president of ARVO, the most prestigious vision research organization in the world,” says Timothy W. Olsen, director of Emory Eye Center. “Jeff’s extraordinary service is well recognized with his selection as president. All of us at the Emory Eye Center are very proud of his recognition and look forward to his positive influence on the organization!”

At Emory Eye Center, Boatright uses molecular and cellular biology techniques to study DNA repair mechanisms with the goal of using them to repair genomic DNA mutations that lead to blindness. He also uses in-vivo pharmacological approaches to explore the effects of hydrophilic bile acids and other atypical compounds on animal models of retinal degeneration and glaucoma. This work is funded by Foundation Fighting Blindness, an unrestricted grant from Research to Prevent Blindness (RPB), the Katz Foundation, and the National Eye Institute (NEI) of the National Institutes of Health (NIH).

Within ARVO, Boatright is the trustee for the Biochemistry and Molecular Biology Section; and chairman of the Young Investigators Committee. Within the National Eye Institute (NEI), one of the centers of the NIH, he has served on numerous study sections. He is on the board of directors for the Foundation Fighting Blindness, Georgia affiliate, and was honored as their Scientist of the Year in 2007. At Emory, he serves on numerous institutional and departmental committees, including Emory University’s Institutional Animal Care and Use Committee (IACUC), the Ocular Predictive Health Committee, and as director of the Redmond-Firman Center for Glaucoma Research at the Eye Center.

He is founding and current editor-in-chief of Molecular Vision, a peer-reviewed journal dedicated to the dissemination of research results in molecular biology, cell biology and the genetics of the visual system. Molecular Vision is ranked second in Impact Factor and first in Immediacy Index in a field of 14 vision research journals. It is ranked in the top 13% of all journals. It is used as an Open Access publishing exemplar by the National Library of Medicine and by the NIH Library. The journal is supported by Knights Templar and through initiatives generated within Emory Eye Center. Additionally, he has served on the Editorial Review Board of International Journal of Molecular Sciences since 2001.

In addition to ARVO, he holds memberships in American Association for the Advancement of Science, the Society for Neuroscience, and the International Society for Eye Research. This year, he was tapped as a Silver Fellow of ARVO, an honor that recognizes members for their accomplishments, leadership, and contributions to the Association.

Boatright is principal investigator (PI) or co-investigator in four NEI grants and four private foundation grants.


Our Emory campus location:

Copyright © Emory Eye Center - All Rights Reserved | Emory Clinic Building B, 1365B Clifton Road, NE, Atlanta, Georgia 30322 USA